Oct 20, 2026
1:20
For every 20 shares held, investors received 1.
The split itself did not change the total investment value.
Moleculin Biotech, Inc. (GETTEX:MOL) operates in the Pharmaceuticals: major industry.
Moleculin Biotech, Inc. company overviewMoleculin Biotech, Inc.'s most recent stock split was on October 20, 2026. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Moleculin Biotech, Inc. (GETTEX:MOL) has split its stock 4 times: a 1-for-6 reverse split on February 1, 2021, a 1-for-15 reverse split on March 22, 2024, a 1-for-25 reverse split on December 1, 2025, and a 1-for-20 reverse split on October 20, 2026.
Moleculin Biotech, Inc. has split its stock 4 times. This history records 4 reverse splits between February 1, 2021 and October 20, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Moleculin Biotech, Inc.'s 1-for-20 reverse split on October 20, 2026, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Moleculin Biotech, Inc. has not announced a new split in our records. Its most recent split was on October 20, 2026, less than a year ago. Companies announce splits in advance, and any new GETTEX:MOL split will appear on this page.